Human Growth Hormone Market Size, Share, Analysis Report

Human Growth Hormone Market Size By Route Of Administration (Intravenous, Intramuscular, Subcutaneous, Oral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Pharmacy), By Application (Growth Hormone Deficiency, Prader-Willi Syndrome, Turner Syndrome, Small for Gestational Age), (By Region (North America, Europe, Asia-Pacific, Rest of the World), Market Analysis Report, Forecast

The global Human Growth Hormone Market is expected to reach US$ 8500 million by 2028, registering a CAGR of 9.0% from 2023 to 2028.

Purchase User License

MARKET SNAPSHOT

Major Players

  • Merck KGaA
  • Novartis AG
  • Ipsen S.A
  • GeneScience Pharmaceuticals Co. Ltd
  • Eli Lily and Company
  • Study period:

    2023-2028

    Base Year:

    2022

    CAGR:

    5

    Fastest Growing Market:

    APAC

    Largest Market:

    North America

    REPORT DESCRIPTION

    The development of recombinant human growth hormone treatments, the rise in pituitary dysfunction cases, and the rise in off-label use of human growth hormones are all key drivers driving market expansion.

    The pituitary gland does not manufacture enough concentrations of human growth hormones in humans, resulting in growth hormone insufficiency. Subcutaneous injections of recombinant human growth hormones are used to treat this deficit. Growth hormone insufficiency can also be caused by genetic illnesses including Prader-Willi syndrome and Turner syndrome, which can lead to delayed puberty and shorter-than-average height.

    The global Human Growth Hormone Market is expected to reach US$ 8500 million by 2028, registering a CAGR of 9.0% from 2023 to 2028.

    The global Human Growth Hormone market is segregated on the basis of Route Of Administration as Intravenous, Intramuscular, Subcutaneous, and Oral. Based on Distribution Channel the global Human Growth Hormone market is segmented in Hospital Pharmacy, Retail Pharmacy, Clinics, and Online Pharmacy. Based on Application the global Human Growth Hormone market is segmented in Growth Hormone Deficiency, Prader-Willi Syndrome, Turner Syndrome, Small for Gestational Age, and Others.

    The global Human Growth Hormone market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Human Growth Hormone market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

    Competitive Rivalry

    Merck KGaA, Novartis AG, GeneScience Pharmaceuticals Co. Ltd, Ipsen S.A., Eli Lily and Company, Novo Nordisk A/S, Zhongshan Hygene Biopharm Co. Ltd, Lifetech Labs, Biopartners GmbH, Genetech Inc., Pfizer Inc., Anhui Anke Biotechnology (Group) Co. Ltd, and others are among the major players in the global Human Growth Hormone market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

    The Human Growth Hormone Market has been segmented as below:

    Human Growth Hormone Market, By Route Of Administration

    • Intravenous
    • Intramuscular
    • Subcutaneous
    • Oral

    Human Growth Hormone Market, By Distribution Channel

    • Hospital Pharmacy
    • Retail Pharmacy
    • Clinics
    • Online Pharmacy

    Human Growth Hormone Market, By Application

    • Growth Hormone Deficiency
    • Prader-Willi Syndrome
    • Turner Syndrome
    • Small for Gestational Age
    • Others

    Human Growth Hormone Market, By Region

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    Human Growth Hormone Market, By Company

    • Merck KGaA
    • Novartis AG
    • GeneScience Pharmaceuticals Co. Ltd
    • Ipsen S.A.
    • Eli Lily and Company
    • Novo Nordisk A/S
    • Zhongshan Hygene Biopharm Co. Ltd
    • Lifetech Labs
    • Biopartners GmbH
    • Genetech Inc.
    • Pfizer Inc.
    • Anhui Anke Biotechnology (Group) Co. Ltd

    The report covers:

    • Global Human Growth Hormone market sizes from 2021 to 2028, along with CAGR for 2023-2028
    • Market size comparison for 2022 vs 2028, with actual data for 2022, estimates for 2023 and forecast from 2024 to 2028
    • Global Human Growth Hormone market trends, covering comprehensive range of consumer trends & manufacturer trends
    • Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Human Growth Hormone market
    • Major market opportunities and challenges in forecast timeframe to be focused
    • Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
    • Comprehensive company profiles of the key industry players

    Report Scope:

    The global Human Growth Hormone market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Human Growth Hormone market share. Major industry players with significant revenue share include Merck KGaA, Novartis AG, GeneScience Pharmaceuticals Co. Ltd, Ipsen S.A., Eli Lily and Company, Novo Nordisk A/S, Zhongshan Hygene Biopharm Co. Ltd, Lifetech Labs, Biopartners GmbH, Genetech Inc., Pfizer Inc., Anhui Anke Biotechnology (Group) Co. Ltd, and others.

    Reasons to Buy this Report:

    • Gain detailed insights on the Human Growth Hormone industry trends
    • Find complete analysis on the market status
    • Identify the Human Growth Hormone market opportunities and growth segments
    • Analyse competitive dynamics by evaluating business segments & product portfolios
    • Facilitate strategy planning and industry dynamics to enhance decision making

    Customization

    Customized report as per the requirement can be offered with appropriate recommendations.

    Below are our New Reports :-

    Personal and Homecare Robotics Market

    Skincare Market

    Medical Device Connectivity Market

    Topical Use Acne Treatment Market

    Healthcare Mobility Solutions Market

    1. Introduction

    1.1 Key Insights
    1.2 Report Overview
    1.3 Markets Covered
    1.4 Stakeholders

    2. Research Methodology

    2.1 Research Scope
    2.2 Market Research Process
    2.3 Research Data Analysis
    2.4.1 Secondary Research
    2.4.2 Primary Research
    2.4.3 Models for Estimation
    2.5 Market Size Estimation
    2.5.1 Bottom-Up Approach – Segmental Market Analysis
    2.5.2 Top-Down Approach – Parent Market Analysis

    3. Executive Summary

    4. Market Overview

    4.1 Introduction
    4.2.1 Drivers
    4.2.2 Restraints
    4.2.3 Opportunities
    4.2.4 Challenges
    4.2 Porter’s Five Force Analysis

    5. Human Growth Hormone Market, By Route of Administration

    5.1 Introduction
    5.2 Intravenous
    5.2.1 Market Overview
    5.2.2 Market Size and Forecast
    5.3 Intramuscular
    5.3.1 Market Overview
    5.3.2 Market Size and Forecast
    5.4 Subcutaneous
    5.4.1 Market Overview
    5.4.2 Market Size and Forecast
    5.5 Oral
    5.5.1 Market Overview
    5.5.2 Market Size and Forecast

    6. Human Growth Hormone Market, By Distribution Channel

    6.1 Introduction
    6.2 Hospital Pharmacy
    6.2.1 Market Overview
    6.2.2 Market Size and Forecast
    6.3 Retail Pharmacy
    6.3.1 Market Overview
    6.3.2 Market Size and Forecast
    6.4 Clinics
    6.4.1 Market Overview
    6.4.2 Market Size and Forecast
    6.5 Online Pharmacy
    6.5.1 Market Overview
    6.5.2 Market Size and Forecast

    7. Human Growth Hormone Market, By Application

    7.1 Introduction
    7.2 Growth Hormone Deficiency
    7.2.1 Market Overview
    7.2.2 Market Size and Forecast
    7.3 Prader-Willi Syndrome
    7.3.1 Market Overview
    7.3.2 Market Size and Forecast
    7.4 Turner Syndrome
    7.4.1 Market Overview
    7.4.2 Market Size and Forecast
    7.5 Small for Gestational Age
    7.5.1 Market Overview
    7.5.2 Market Size and Forecast
    7.6 Others
    7.6.1 Market Overview
    7.6.2 Market Size and Forecast

    8. Human Growth Hormone Market, By Geography

    8.1 Introduction
    8.2 North America
    8.2.1 North America Human Growth Hormone, By Route Of Administration
    8.2.2 North America Human Growth Hormone, By Distribution Channel
    8.2.3 North America Human Growth Hormone, By Application
    8.3 Europe
    8.3.1 Europe Human Growth Hormone, By Route Of Administration
    8.3.2 Europe Human Growth Hormone, By Distribution Channel
    8.3.3 Europe Human Growth Hormone, By Application
    8.4 Asia-Pacific
    8.4.1 Asia-Pacific Human Growth Hormone, By Route Of Administration
    8.4.2 Asia-Pacific Human Growth Hormone, By Distribution Channel
    8.4.3 Asia-Pacific Human Growth Hormone, By Application
    8.5 Rest of the World
    8.5.1 Rest of the World Human Growth Hormone, By Route Of Administration
    8.5.2 Rest of the World Human Growth Hormone, By Distribution Channel
    8.5.3 Rest of the World Human Growth Hormone, By Application

    9. Competitive Insights

    9.1 Key Insights
    9.2 Company Market Share Analysis
    9.3 Strategic Outlook
    9.3.1 Mergers & Acquisitions
    9.3.2 New Product Development
    9.3.3 Portfolio/Production Capacity Expansions
    9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements 
    9.3.5 Others

    10. Company Profiles

    10.1 Merck KGaA
    10.1.1 Company Overview
    10.1.2 Product/Service Landscape
    10.1.3 Financial Overview
    10.1.4 Recent Developments
    10.2 Novartis AG
    10.2.1 Company Overview
    10.2.2 Product/Service Landscape
    10.2.3 Financial Overview
    10.2.4 Recent Developments
    10.3 GeneScience Pharmaceuticals Co. Ltd
    10.3.1 Company Overview
    10.3.2 Product/Service Landscape
    10.3.3 Financial Overview
    10.3.4 Recent Developments
    10.4 Ipsen S.A.
    10.4.1 Company Overview
    10.4.2 Product/Service Landscape
    10.4.3 Financial Overview
    10.4.4 Recent Developments
    10.5 Eli Lily and Company
    10.5.1 Company Overview
    10.5.2 Product/Service Landscape
    10.5.3 Financial Overview
    10.5.4 Recent Developments
    10.6 Novo Nordisk A/S
    10.6.1 Company Overview
    10.6.2 Product/Service Landscape
    10.6.3 Financial Overview
    10.6.4 Recent Developments
    10.7 Zhongshan Hygene Biopharm Co. Ltd
    10.7.1 Company Overview
    10.7.2 Product/Service Landscape
    10.7.3 Financial Overview
    10.7.4 Recent Developments
    10.8 Lifetech Labs
    10.8.1 Company Overview
    10.8.2 Product/Service Landscape
    10.8.3 Financial Overview
    10.8.4 Recent Developments
    10.9 Biopartners GmbH
    10.9.1 Company Overview
    10.9.2 Product/Service Landscape
    10.9.3 Financial Overview
    10.9.4 Recent Developments
    10.10 Genetech Inc.
    10.10.1 Company Overview
    10.10.2 Product/Service Landscape
    10.10.3 Financial Overview
    10.10.4 Recent Developments
    10.11 Pfizer Inc.
    10.11.1 Company Overview
    10.11.2 Product/Service Landscape
    10.11.3 Financial Overview
    10.11.4 Recent Developments
    10.12 Anhui Anke Biotechnology (Group) Co. Ltd
    10.12.1 Company Overview
    10.12.2 Product/Service Landscape
    10.12.3 Financial Overview
    10.12.4 Recent Developments

    The Human Growth Hormone Market has been segmented as below:

    Human Growth Hormone Market, By Route Of Administration

    • Intravenous
    • Intramuscular
    • Subcutaneous
    • Oral

    Human Growth Hormone Market, By Distribution Channel

    • Hospital Pharmacy
    • Retail Pharmacy
    • Clinics
    • Online Pharmacy

    Human Growth Hormone Market, By Application

    • Growth Hormone Deficiency
    • Prader-Willi Syndrome
    • Turner Syndrome
    • Small for Gestational Age
    • Others

    Human Growth Hormone Market, By Region

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    Human Growth Hormone Market, By Company

    • Merck KGaA
    • Novartis AG
    • GeneScience Pharmaceuticals Co. Ltd
    • Ipsen S.A.
    • Eli Lily and Company
    • Novo Nordisk A/S
    • Zhongshan Hygene Biopharm Co. Ltd
    • Lifetech Labs
    • Biopartners GmbH
    • Genetech Inc.
    • Pfizer Inc.
    • Anhui Anke Biotechnology (Group) Co. Ltd

    Got a question? We've got answers. If you have some other questions, see our support center.

    The segment included in Human Growth Hormone market is Route Of Administration, Distribution Channel, Application and region.
    Some key players operating in the Human Growth Hormone market include Merck KGaA, Novartis AG, GeneScience Pharmaceuticals Co. Ltd, Ipsen S.A., Eli Lily and Company, Novo Nordisk A/S, Zhongshan Hygene Biopharm Co. Ltd
    We can offer several formats of the market research reports including, • PDF • PPT • Spreadsheet/ Workbook
    The market is expected to grow at a CAGR of 9% during the study period (2023-2028)
    The global Human Growth Hormone Market is expected to reach US$ 8500 million by 2028

    Related Reports